The last decade has witnessed a significant advancement in medical science and technologies. The cell and gene therapies represent remarkable outcomes of such progress achieved in a very short timeframe. The COVID-19 pandemic has created roadblocks for patients to access hospitals for diagnosis and treatments since the onset of its first-wave. On the contrary, this one-year leap has witnessed unprecedented technological advances, especially in terms of mRNA-based therapies and their regulations. The present review focuses on CAR-T as a model with all key attributes and implications in complicated chains from early science to a variety of models and trends in clinical practice.
CITATION STYLE
Samsonov, M. Y., & Lomonosov, A. M. (2021). What we are learning from CAR-T implementation: Development, regulatory and clinical practices. Cellular Therapy and Transplantation, 10(2), 26–36. https://doi.org/10.18620/CTT-1866-8836-2021-10-2-26-36
Mendeley helps you to discover research relevant for your work.